# The Diabetes Virus Detection and Intervention Trial

> **NCT04838145** · PHASE2 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 96 (actual)

## Conditions studied

- Type1 Diabetes Mellitus
- Enterovirus

## Interventions

- **DRUG:** Ribavirin + Pleconaril
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04838145
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-10-25
- **Final completion:** 2020-10-25
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838145, "The Diabetes Virus Detection and Intervention Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04838145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*